Author:
Kurnit Katherine C.,Coleman Robert L.,Westin Shannon N.
Funder
National Institutes of Health
University of Texas MD Anderson Cancer Center
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference48 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
https://doi.org/10.3322/caac.21442
.
2. Network NCC. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer (version 2.2018).
https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf
. Accessed 29 June 2018.
3. Pommier Y, O’Connor MJ, de Bono J. Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action. Sci Transl Med. 2016;8:362):362 ps17.
https://doi.org/10.1126/scitranslmed.aaf9246
.
4. Ronson GE, Piberger AL, Higgs MR, Olsen AL, Stewart GS, McHugh PJ, et al. PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation. Nat Commun. 2018;9(1):746.
https://doi.org/10.1038/s41467-018-03159-2
.
5. Scott CL, Swisher EM, Kaufmann SH. Poly (ADP-ribose) polymerase inhibitors: recent advances and future development. J Clin Oncol. 2015;33(12):1397–406.
https://doi.org/10.1200/jco.2014.58.8848
.
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献